SAN DIEGO, Jan. 7, 2016 /PRNewswire/ -- BioDuro, LLC, a global CRO leader focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharmaceutical partners, announced today the appointment of Ian R Wisenberg as Chief Financial Officer. Mr. Wisenberg joins the company after having served for the past seven years as Managing Director of BioGlobal Consulting Group where he worked closely with several growth companies including Genalyte, Intrinsic Lifesciences, Excaliard Pharmaceuticals, and more recently Molecular Response and Formex. Mr. Wisenberg also served as Chief Business Officer for the Biotech Investment Group, a San Diego private equity firm.

"I am thrilled to welcome Ian to BioDuro's senior management team," said Cyrus Mirsaidi, President & CEO of BioDuro. "I have worked with Ian over several years on many projects, on both sides of the table, and have tremendous respect for his abilities. Ian brings executive level strategic and operational biotech insight to BioDuro. His previous experience in doing business in China is critical to our company, and he will play a key leadership role as we continue to grow and increase our service offerings to our customers."

From January 2009 to December 2012, Mr. Wisenberg served as Managing Director for ChinaBio Capital Partners supporting business and corporate development efforts for innovative biopharmaceutical initiatives focused to serve the Chinese market.

"I am pleased to have joined the BioDuro team at a very exciting time in the company's evolution," said Ian Wisenberg. "BioDuro is uniquely positioned with its ability to provide fully integrated drug discovery, formulation and manufacturing services to the life sciences industry. I am especially attracted to BioDuro's 10 years of excellence and branding and being well positioned to fulfill the ever-increasing needs of our customers."

Mr. Wisenberg holds a B.Com from University of Cape Town, and is licensed as a C.P.A. (inactive) in the State of California. He resides in San Diego with his wife and two sons.

BioDuro is a leading life sciences research organization that provides biopharmaceutical clients with comprehensive, integrated drug discovery services spanning target identification through IND filing. With depth and breadth of therapeutic expertise in small molecule discovery, and large molecular development and scale up, combined with unique technology platforms, BioDuro is well positioned to help clients significantly accelerate their lead discovery programs. www.bioduro.com

SOURCE: BioDuro, LLC